Today: 19 June 2026
Browse Category

Earnings Reports 11 January 2026 - 12 January 2026

Kroger maintained its 2026 outlook after first-quarter sales exceeded forecasts, but adjusted earnings missed estimates by a cent. Shares fell in premarket trading due to margin pressure from price investments, higher transport costs, and changes in fuel mix. CarMax reported fiscal Q1 revenue of $8.01 billion, beating forecasts, driven by higher used-car prices and strong wholesale demand, though retail used-vehicle gross profit per unit declined and the company continued price cuts to boost sales. La-Z-Boy shares rebounded nearly 17% in after-hours trading after adjusted earnings beat expectations, with revenue flat year-over-year; retail expansion supported results, but same-store orders and Joybird sales remained weak. Micron Technology shares dropped 3.6% after a record close as semiconductor stocks slipped, with investors locking in profits rather than reacting to specific company news. Netflix shares declined amid deal speculation involving Roku and Lionsgate, with the next earnings date set for July 16; the stock’s outlook depends on ads, pricing, and engagement. AT&T shares dipped 1.23% before a slight premarket uptick, underperforming the broader market as telecom stocks were influenced more by rate changes than company news; its Q2 earnings call is upcoming. Dave & Buster’s shares fell 4.72% after earnings missed on revenue, profit, and comps, raising questions about future sales and free-cash-flow targets. Nokia shares dropped 3.32% in Helsinki after a recent surge, with its ADR slightly up in New York; the company is set to report soon. Ford shares lagged the S&P 500, with the company seeking to continue importing China-built Lincoln Nautilus as new U.S. rules for connected-car software approach.
Abercrombie & Fitch stock dives after holiday update trims sales outlook — what investors watch next

Abercrombie & Fitch stock dives after holiday update trims sales outlook — what investors watch next

Abercrombie & Fitch shares fell about 20% Monday after the retailer cut its holiday-quarter outlook and trimmed its full-year sales growth forecast to at least 6%. The company cited higher planned spending and $90 million in tariff costs in its revised guidance. Fourth-quarter net sales are now projected to rise around 5%, below analyst estimates. Capital expenditure targets increased to $245 million.
12 January 2026
··
Tesla stock pops at the open as robotaxi “prove-it year” talk meets earnings countdown

Tesla stock pops at the open as robotaxi “prove-it year” talk meets earnings countdown

Tesla shares rose 2.1% to $445.01 in early New York trading Monday. The company delivered 418,227 vehicles in the fourth quarter, about 1% below analyst estimates, but set a record for energy storage deployments. Rivian, GM, and Ford all traded lower. Tesla is set to report earnings Jan. 28, with investors focused on robotaxi updates and profitability.
12 January 2026
·······
Citigroup stock slides as Trump’s 10% credit-card rate cap plan rattles lenders ahead of earnings

Citigroup stock slides as Trump’s 10% credit-card rate cap plan rattles lenders ahead of earnings

Citigroup shares fell 3.5% to $117.03 after President Trump proposed a one-year 10% cap on credit card interest rates, with no details on enforcement. Analysts said such a cap would likely require congressional action. The Supreme Court declined to hear Citigroup’s appeal in a fraud lawsuit tied to its Banamex unit, allowing the case to proceed. Capital One and American Express also dropped sharply.
12 January 2026
··
Tempus AI stock jumps in premarket after $1.27 billion revenue preview, contract value tops $1.1 billion

Tempus AI stock jumps in premarket after $1.27 billion revenue preview, contract value tops $1.1 billion

Tempus AI shares rose about 11% in premarket trading Monday after the company reported preliminary 2025 revenue of $1.27 billion, up 83% year-on-year, and record contract value exceeding $1.1 billion. The company cited strong growth in both Diagnostics and Data segments, with over 70 new data agreements signed in 2025. Tempus noted the results are unaudited and subject to change.
12 January 2026
·······
British American Tobacco shares rise on buyback update — what to watch before Feb. 12 results

British American Tobacco shares rise on buyback update — what to watch before Feb. 12 results

British American Tobacco shares rose 1.2% to 4,110p in early London trading Monday after announcing more share buybacks. On Jan. 9, BAT bought 132,817 shares at an average 4,015p each, planning to cancel them and reduce the share count to 2.18 billion. The buyback program is now set at £1.3 billion for 2026. Full-year 2025 results are due Feb. 12.
12 January 2026
··
Keppel Ltd stock edges higher in Singapore — here’s what traders are watching into Feb. 5 results

Keppel Ltd stock edges higher in Singapore — here’s what traders are watching into Feb. 5 results

Keppel shares rose 0.67% to S$10.54 in Monday afternoon trading, near a 52-week high, with about 1 million shares changing hands. Investors are awaiting Keppel’s full-year results, due Feb. 5. The Straits Times Index also gained 0.67% by late morning. Markets abroad slipped after Fed Chair Powell said the Trump administration threatened him with indictment.
12 January 2026
···
SGX stock edges up as Nasdaq dual-listing rules move to Feb 8 deadline; Singapore Exchange earnings next

SGX stock edges up as Nasdaq dual-listing rules move to Feb 8 deadline; Singapore Exchange earnings next

Shares of Singapore Exchange rose 0.5% to S$17.59 by 3:10 p.m. Monday after regulators launched consultations on rule changes to simplify SGX-Nasdaq dual listings. MAS proposed allowing a single prospectus for simultaneous IPOs and earlier retail investor engagement. Securities turnover at SGX jumped 29% year-on-year in December to S$25.8 billion. Feedback on the proposed changes is due by Feb. 8.
12 January 2026
···
CapitaLand Investment stock ticks up as rate-cut bets firm; Feb 11 results in view

CapitaLand Investment stock ticks up as rate-cut bets firm; Feb 11 results in view

CapitaLand Investment shares rose 0.7% to S$2.91 Monday afternoon, extending last week’s gains as institutional investors logged S$63 million in net inflows to Singapore stocks in early 2026. Market focus remains on borrowing costs, with UOB forecasting Singapore’s Sora rate may bottom in Q2 as U.S. rate cuts loom. CapitaLand Investment will release unaudited full-year results on Feb. 11.
12 January 2026
···
Snap stock slides to $8 as CEO share sale surfaces; CPI, earnings date loom

Snap stock slides to $8 as CEO share sale surfaces; CPI, earnings date loom

Snap Inc. shares fell 2.3% Friday to $8.21, marking a third straight decline and leaving the stock near the bottom of its 52-week range. CEO Evan Spiegel sold over 1.2 million shares on Jan. 5 under a pre-arranged plan, according to a recent filing. The broader Nasdaq rose 0.81% the same day. Investors await Tuesday’s U.S. inflation data and Snap’s next earnings report, expected in early February.
12 January 2026
···
Apple stock eyes January 29 earnings after rare losing streak; Evercore lifts target, keeps “top pick”

Apple stock eyes January 29 earnings after rare losing streak; Evercore lifts target, keeps “top pick”

Apple shares closed Friday up 0.1% at $259.37, ending a rare losing streak. Evercore ISI raised its price target to $330, citing strong iPhone demand. Investors are focused on Apple’s Jan. 29 earnings for updates on iPhone sales and “Apple Intelligence.” Rising memory costs and supplier moves add pressure ahead of the report.
12 January 2026
···
American Airlines stock gets a fresh upgrade — what AAL investors watch as airline earnings kick off

American Airlines stock gets a fresh upgrade — what AAL investors watch as airline earnings kick off

American Airlines shares rose 1.7% to $15.99 Friday after Susquehanna upgraded the stock and raised its price target to $20, citing new revenue strategies and an improved outlook. The move comes as U.S. airline earnings season begins, with Delta reporting Jan. 13. American also announced new First Class barbecue meals and free Wi-Fi for loyalty members. Rising fuel costs remain a concern for the sector.
12 January 2026
··
Trade Desk stock ends the week flat near $37 as CPI and earnings season set the next test

Trade Desk stock ends the week flat near $37 as CPI and earnings season set the next test

The Trade Desk closed Friday at $37.29, trading between $36.63 and $37.65 on volume of 10.2 million shares. Investors are awaiting Tuesday’s U.S. inflation data, which could sway growth stocks and rate expectations. Wall Street ended the week at record highs despite a weak jobs report. Trade Desk’s results remain pending as earnings season begins.
12 January 2026
···
1 … 150 151 152 153 154 … 257

Stock Market Today

  • SanDisk Stock Surges Over 4,000% on AI NAND Flash Shortage—What’s Next for SNDK
    June 19, 2026, 12:16 AM EDT. SanDisk (SNDK) shares have surged more than 4,000% since their 2025 spinoff from Western Digital, fueled by a genuine shortage of AI-grade NAND flash memory used in enterprise solid-state drives (SSDs). Trading near $1,959 on June 17, 2026, SNDK's rally reflects soaring demand in AI data center storage amid limited supply and a newly spun-off, thin share structure. Analysts remain overwhelmingly positive with a consensus 'buy.' However, the stock's steep ascent raises questions about valuation sustainability despite strong fundamentals, including $13.2 billion in trailing revenue and $4.5 billion net income. The supply-demand imbalance, pricing power, and margin expansion in AI storage markets underpin the momentum, positioning SanDisk as a key player in the ongoing AI storage upcycle.

Latest articles

Kardigan pops in first Nasdaq trading after $400 million IPO

Kardigan pops in first Nasdaq trading after $400 million IPO

19 June 2026
Kardigan surged 37.5% above its $16 IPO price to close at $22 after raising $400 million in an upsized Nasdaq debut, signaling renewed investor appetite for large biotech IPOs as the company advances three late-stage cardiovascular drug candidates.
Go toTop